Literature DB >> 26414465

Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy.

Michael L Wang1, Nathanael G Bailey.   

Abstract

Acute myeloid leukemia is a category of diseases with a common aggressive clinical presentation but with a prognosis and management that is dependent upon the underlying genetic characteristics of the neoplasm. The purpose of this brief review is to update the practicing pathologist on the current standard of care in the genetic evaluation of acute myeloid leukemia and to highlight future directions in the classification, genetic assessment, and management of these devastating diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26414465     DOI: 10.5858/arpa.2015-0203-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  16 in total

1.  Evaluation of cyclin A1-specific T cells as a potential treatment for acute myeloid leukemia.

Authors:  Wingchi K Leung; Aster Workineh; Shivani Mukhi; Ifigeneia Tzannou; Daniel Brenner; Norihiro Watanabe; Ann M Leen; Premal Lulla
Journal:  Blood Adv       Date:  2020-01-28

2.  Prolyl oligopeptidase inhibitor suppresses the upregulation of ACSDKP in patients with acute myeloid leukemia.

Authors:  Haiwu Cao; Xiaohong Zhao; Shiyun Lu; Zhi Wang
Journal:  Exp Ther Med       Date:  2018-04-30       Impact factor: 2.447

3.  Inhibition of pentose phosphate pathway suppresses acute myelogenous leukemia.

Authors:  Yan Chen; Qian Xu; Dexiang Ji; Yanlin Wei; Huamei Chen; Tingting Li; Bolin Wan; Liya Yuan; Ruibin Huang; Guoan Chen
Journal:  Tumour Biol       Date:  2015-11-23

4.  Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase.

Authors:  Salvatore Nicola Bertuccio; Salvatore Serravalle; Annalisa Astolfi; Annalisa Lonetti; Valentina Indio; Anna Leszl; Andrea Pession; Fraia Melchionda
Journal:  Oncotarget       Date:  2017-06-19

5.  Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia.

Authors:  Victor Pallarès; Montserrat Hoyos; M Carmen Chillón; Eva Barragán; M Isabel Prieto Conde; Marta Llop; Aïda Falgàs; María Virtudes Céspedes; Pau Montesinos; Josep F Nomdedeu; Salut Brunet; Miguel Ángel Sanz; Marcos González-Díaz; Jorge Sierra; Ramon Mangues; Isolda Casanova
Journal:  Cancers (Basel)       Date:  2018-11-13       Impact factor: 6.639

6.  Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression.

Authors:  L C Stetson; Dheepa Balasubramanian; Susan Pereira Ribeiro; Tammy Stefan; Kalpana Gupta; Xuan Xu; Slim Fourati; Anne Roe; Zachary Jackson; Robert Schauner; Ashish Sharma; Banumathi Tamilselvan; Samuel Li; Marcos de Lima; Tae Hyun Hwang; Robert Balderas; Yogen Saunthararajah; Jaroslaw Maciejewski; Thomas LaFramboise; Jill S Barnholtz-Sloan; Rafick-Pierre Sekaly; David N Wald
Journal:  Leukemia       Date:  2021-07-09       Impact factor: 12.883

7.  Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.

Authors:  Chun Hang Au; Anna Wa; Dona N Ho; Tsun Leung Chan; Edmond S K Ma
Journal:  Diagn Pathol       Date:  2016-01-22       Impact factor: 2.644

8.  NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients.

Authors:  Victor Pallarès; Montserrat Hoyos; M Carmen Chillón; Eva Barragán; M Isabel Prieto Conde; Marta Llop; María Virtudes Céspedes; Josep F Nomdedeu; Salut Brunet; Miguel Ángel Sanz; Marcos González-Díaz; Jorge Sierra; Isolda Casanova; Ramon Mangues
Journal:  Oncotarget       Date:  2017-06-16

9.  Aberrant Methylation of APAF-1 Gene in Acute Myeloid Leukemia Patients.

Authors:  Shahrbano Rostami; Fatemeh Nadali; Reza Alibakhshi; Farhad Zaker; Nahid Nasiri; Mehrdad Payandeh; Bahram Chahardouli; Ali Maleki
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01

10.  Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia.

Authors:  Xuelian Hu; Haodong Cai; Lu Zheng; Yi Luo; Jing Zhou; Yan Hui; Zhenyu Dai; Haolong Lin; Dengju Li; Yi Xiao; Liang Huang; Jianfeng Zhou
Journal:  Cancer Med       Date:  2020-05-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.